{"id":75573,"date":"2026-08-20T12:10:13","date_gmt":"2026-08-20T04:10:13","guid":{"rendered":"https:\/\/flcube.com\/?p=75573"},"modified":"2026-08-20T12:10:14","modified_gmt":"2026-08-20T04:10:14","slug":"vectorbuilder-and-lir-therapeutics-forge-ai-collaboration-to-optimize-aav-capsids-for-clinical-translation","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=75573","title":{"rendered":"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>VectorBuilder<\/strong> and <strong>Lir Therapeutics<\/strong> announced a <strong>strategic collaboration<\/strong> to integrate their respective technological strengths in applying <strong>artificial intelligence (AI) to AAV capsid optimization<\/strong>. The partnership aims to enhance the biological performance, <strong>manufacturability<\/strong>, and <strong>clinical translation potential<\/strong> of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.<\/p>\n\n\n\n<h2 id=\"h-collaboration-overview\" class=\"wp-block-heading\">Collaboration Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partners<\/strong><\/td><td>VectorBuilder, Lir Therapeutics<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>18 Aug 2026<\/td><\/tr><tr><td><strong>Focus<\/strong><\/td><td>AI\u2011driven AAV capsid optimization<\/td><\/tr><tr><td><strong>Goal<\/strong><\/td><td>Improve biological performance, manufacturability and clinical translation of high\u2011potential AAVs<\/td><\/tr><tr><td><strong>Approach<\/strong><\/td><td>Optimize proven capsid candidates rather than designing novel ones from scratch<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-complementary-ai-platforms\" class=\"wp-block-heading\">Complementary AI Platforms<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>VectorBuilder \u2013 DeepCap:<\/strong> An AI platform for discovering high\u2011potential <strong>AAV capsids<\/strong> with demonstrated biological potential.<\/li>\n\n\n\n<li><strong>Lir Therapeutics \u2013 nAAVigator:<\/strong> An <strong>AI\u2011driven optimization platform<\/strong> coupled with a <strong>&#8220;lab\u2011in\u2011the\u2011loop&#8221;<\/strong> process to further engineer select capsids discovered via DeepCap.<\/li>\n\n\n\n<li><strong>Strategy:<\/strong> Rather than designing entirely novel capsids from scratch, the partners will focus on <strong>optimizing already promising candidates<\/strong> \u2014 a de\u2011risked route to clinically viable vectors.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-key-optimization-goals\" class=\"wp-block-heading\">Key Optimization Goals<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Objective<\/th><th>Target Outcome<\/th><\/tr><\/thead><tbody><tr><td><strong>Production Efficiency<\/strong><\/td><td>Improved process robustness and scalability<\/td><\/tr><tr><td><strong>Product Quality<\/strong><\/td><td>Higher yields of full capsids and better final product quality<\/td><\/tr><tr><td><strong>Dosing<\/strong><\/td><td>Reduced potential therapeutic dosages<\/td><\/tr><tr><td><strong>Specificity<\/strong><\/td><td>Enhanced tissue targeting with minimized off\u2011target delivery<\/td><\/tr><tr><td><strong>Safety<\/strong><\/td><td>Lower immunogenicity<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Manufacturing as the Bottleneck:<\/strong> For AAV gene therapies, capsid manufacturability and product quality are among the key barriers to clinical and commercial success \u2014 making this a high\u2011value focus for the partnership.<\/li>\n\n\n\n<li><strong>De\u2011Risked Development Model:<\/strong> Optimizing validated capsids rather than starting from scratch shortens development timelines and raises the probability of clinical translation.<\/li>\n\n\n\n<li><strong>Platform Synergy:<\/strong> Combining DeepCap&#8217;s discovery capability with nAAVigator&#8217;s lab\u2011in\u2011the\u2011loop optimization creates an end\u2011to\u2011end AI workflow spanning capsid discovery through clinical\u2011grade engineering.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the collaboration&#8217;s optimization goals and clinical translation potential. Actual results may differ due to risks including platform performance, development outcomes, regulatory considerations, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[4906,1405],"class_list":["post-75573","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-lir-therapeutics","tag-vectorbuilder"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in applying artificial intelligence (AI) to AAV capsid optimization. The partnership aims to enhance the biological performance, manufacturability, and clinical translation potential of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=75573\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation\" \/>\n<meta property=\"og:description\" content=\"VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in applying artificial intelligence (AI) to AAV capsid optimization. The partnership aims to enhance the biological performance, manufacturability, and clinical translation potential of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=75573\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-20T04:10:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T04:10:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75573#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75573\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation\",\"datePublished\":\"2026-08-20T04:10:13+00:00\",\"dateModified\":\"2026-08-20T04:10:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75573\"},\"wordCount\":344,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Lir Therapeutics\",\"VectorBuilder\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75573#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75573\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=75573\",\"name\":\"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-20T04:10:13+00:00\",\"dateModified\":\"2026-08-20T04:10:14+00:00\",\"description\":\"VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in applying artificial intelligence (AI) to AAV capsid optimization. The partnership aims to enhance the biological performance, manufacturability, and clinical translation potential of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75573#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75573\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75573#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation - Insight, China&#039;s Pharmaceutical Industry","description":"VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in applying artificial intelligence (AI) to AAV capsid optimization. The partnership aims to enhance the biological performance, manufacturability, and clinical translation potential of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=75573","og_locale":"en_US","og_type":"article","og_title":"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation","og_description":"VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in applying artificial intelligence (AI) to AAV capsid optimization. The partnership aims to enhance the biological performance, manufacturability, and clinical translation potential of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.","og_url":"https:\/\/flcube.com\/?p=75573","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-20T04:10:13+00:00","article_modified_time":"2026-08-20T04:10:14+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=75573#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=75573"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation","datePublished":"2026-08-20T04:10:13+00:00","dateModified":"2026-08-20T04:10:14+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=75573"},"wordCount":344,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Lir Therapeutics","VectorBuilder"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=75573#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=75573","url":"https:\/\/flcube.com\/?p=75573","name":"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-20T04:10:13+00:00","dateModified":"2026-08-20T04:10:14+00:00","description":"VectorBuilder and Lir Therapeutics announced a strategic collaboration to integrate their respective technological strengths in applying artificial intelligence (AI) to AAV capsid optimization. The partnership aims to enhance the biological performance, manufacturability, and clinical translation potential of adeno\u2011associated virus (AAV) capsids, accelerating the path of high\u2011potential AAVs toward clinical applications.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=75573#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=75573"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=75573#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"VectorBuilder and Lir Therapeutics Forge AI Collaboration to Optimize AAV Capsids for Clinical Translation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75573"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75573\/revisions"}],"predecessor-version":[{"id":75574,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75573\/revisions\/75574"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}